A fusion protein comprising pneumococcal surface protein A and a pneumolysin derivate confers protection in a murine model of pneumococcal pneumonia
PspA and pneumolysin are two important vaccine candidates, able to elicit protection in different models of pneumococcal infection. The high immunogenic potential of PspA, combined with a possible adjuvant effect of pneumolysin derivatives (due to their ability to interact with TLR-4) could greatly...
Main Authors: | Tanila Wood dos Santos, Pedro Almeida Gonçalves, Dunia Rodriguez, José Aires Pereira, Carlos Augusto Real Martinez, Luciana C. C. Leite, Lucio F. C. Ferraz, Thiago Rojas Converso, Michelle Darrieux |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728834/?tool=EBI |
Similar Items
-
A fusion protein comprising pneumococcal surface protein A and a pneumolysin derivate confers protection in a murine model of pneumococcal pneumonia.
by: Tanila Wood Dos Santos, et al.
Published: (2022-01-01) -
Fusion of PspA to detoxified pneumolysin enhances pneumococcal vaccine coverage
by: Barbara Milani, et al.
Published: (2023-01-01) -
Immune response induced in mice by a hybrid rPotD-PdT pneumococcal protein.
by: Thiago Rojas Converso, et al.
Published: (2022-01-01) -
The Yin and Yang of Pneumolysin During Pneumococcal Infection
by: Joana M. Pereira, et al.
Published: (2022-04-01) -
Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen
by: Philippe Hermand, et al.
Published: (2017-01-01)